Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::
:::

2020

 

  1. Tap WD*, Wagner AJ, Schöffski P, Martin-Broto J, Krarup-Hansen A, Ganjoo KN, Yen CC, Razak AR, Spira A, Kawai A, Cesne AL, Tine BA, Naito Y, Park SH, Fedenko A, Pápai Z, Soldatenkova V, Shahir A, Mo G, Wright J, Jones RL, ANNOUNCE Investigators.  Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients with Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial. JAMA 2020 Apr; 323(13): 1266-76. (IF: 45.540; Medicine, General & Internal 3/165)

  2. DV Catenacci*, YK Kang, H Park, HE Uronis, KW Lee, MC Ng, PC Enzinger, SH Park, PJ Gold, J Lacy, HS Hochster, SC Oh, YH Kim, KA Marrone, RJ Kelly, RA Juergens, JG Kim, JC Bendell, T Alcindor, SJ Sym, EK Song, CE Chee, Y Chao, S Kim, AC Lockhart, KL Knutson, J Yen, A Franovic, JL Nordstrom, D Li, J Wigginton, JK Davidson-Moncada, MK Rosales, YJ Bang, CP-MGAH- Study Group.  Margetuximab Plus Pembrolizumab in Patients with Previously Treated, HER2-Positive Gastro-Oesophageal Adenocarcinoma (CP-MGAH22-05): a Single-Arm, Phase 1b-2 Trial. Lancet Oncol 2020 Aug; 21(8): 1066-76. Epub 2020 Jul. (IF: 33.752; Oncology 4/244)

  3. Finn RS*, Ryoo BY, Merle P, Kudo M, Bouattour M, Lim HY, Breder V, Edeline J, Chao Y, Ogasawara S, Yau T, Garrido M, Chan SL, Knox J, Daniele B, Ebbinghaus SW, Chen E, Siegel AB, Zhu AX, Cheng AL.  Pembrolizumab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial. J Clin Oncol 2020 Jan; 38(3): 193-202. Epub 2019 Dec. (IF: 28.349; Oncology 5/230)

  4. Chen LT*, Martinelli E, Cheng AL, Pentheroudakis G, Qin S, Bhattacharyya GS, Ikeda M, Lim HY, Ho GF, Choo SP, Ren Z, Malhotra H, Ueno M, Ryoo BY, Kiang TC, Tai D, Vogel A, Cervantes A, Lu SN, Yen CJ, Huang YH, Chen SC, Hsu C, Shen YC, Tabernero J, Yen Y, Hsu CH, Yoshino T, Douillard JY.  Pan-Asian Adapted ESMO Clinical Practice Guidelines for the Management of Patients with Intermediate and Advanced/Relapsed Hepatocellular Carcinoma: a TOS-ESMO Initiative Endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO. Ann Oncol 2020 Mar; 31(3): 334-51. Epub 2019 Dec. (IF: 18.274; Oncology 9/244)

  5. Scagliotti G*, Moro-Sibilot D, Kollmeier J, Favaretto A, Cho EK, Grosch H, Kimmich M, Girard N, Tsai CM, Hsia TC, Brighenti M, Schumann C, Wang XA, Wijayawardana SR, Gruver AM, Wallin J, Mansouri K, Wacheck V, Chang GC.  A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-line Treatment for EGFR-mutation Positive NSCLC Patients. J Thorac Oncol 2020 Jan; 15(1): 80-90. Epub 2019 Oct. (IF: 12.460; Respiratory System 3/63; Oncology 10/230)

  6. Nishio M*, Felip E, Orlov S, Park K, Yu CJ, Tsai CM, Cobo M, McKeage M, Su WC, Mok T, Scagliotti GV, Spigel DR, Viraswami-Appanna K, Chen Z, Passos VQ, Shaw AT.  Final Overall Survival, Other Efficacy and Safety Results from ASCEND-3: Phase II Study of Ceritinib in ALKi-Naïve Patients with ALK-Rearranged Non-Small-Cell Lung Cancer. J Thorac Oncol 2020 Apr; 15(4): 609-17. Epub 2019 Nov. (IF: 12.460; Respiratory System 3/63; Oncology 10/230)

  7. J Desai*, S Deva, JS Lee, CC Lin, CJ Yen, Y Chao, B Keam, M Jameson, MM Hou, YK Kang, B Markman, CH Lu, KM Rau, KH Lee, L Horvath, M Friedlander, A Hill, S Sandhu, P Barlow, CY Wu, Y Zhang, L Liang, J Wu, V Paton, M Millward.  Phase IA/IB Study of Single-Agent Tislelizumab, an Investigational Anti-PD-1 Antibody, in Solid Tumors. J Immunother Cancer 2020 Jun; 8(1): e000453. (IF: 9.913; Immunology 11/158; Oncology 18/244)

  8. Tan KT, Yeh CN, Chang YC, Cheng JH, Fang WL, Yeh YC, Wang YC, Hsu DS, Wu CE, Lai JI, Chang PM, Chen MH, Lu ML, Chen SJ, Chao Y, Hsiao M, Chen MH*.  PRKDC: New Biomarker and Drug Target for Checkpoint Blockade Immunotherapy. J Immunother Cancer 2020 Mar; 8(1): e000485. (IF: 9.913; Immunology 11/158; Oncology 18/244)

  9. PC Lee, Y Chao, MH Chen, KH Lan, IC Lee, MC Hou, YH Huang*.  Risk of HBV Reactivation in Patients with Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma. J Immunother Cancer 2020 Aug; 8(2): e001072. (IF: 9.913; Immunology 11/158; Oncology 18/244)

  10. Kelly RJ*, Lee J, Bang YJ, Almhanna K, Blum Murphy M, Catenacci DVT, Chung HC, Wainberg ZA, Gibson MK, Lee KW, Bendell JC, Denlinger CS, Chee CE, Omori T, Leidner R, Lenz HJ, Chao Y, Rebelatto MC, Brohawn P, He P, McDevitt J, Sheth S, Englert JM, Ku GY.  Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma. Clin Cancer Res 2020 Feb; 26(4): 846-54. Epub 2019 Nov. (IF: 8.911; Oncology 16/230)

  11. TT Liao, CC Lin, JK Jiang, SH Yang, HW Teng, MH Yang*.  Harnessing Stemness and PD-L1 Expression by AT-Rich Interaction Domain-Containing Protein 3B in Colorectal Cancer. Theranostics 2020 May; 10(14): 6095-112. (IF: 8.579; Medicine, Research & Experimental 10/138)

  12. Chen HY, Wang ML, Laurent B, Hsu CH*, Chen MT, Lin LT, Shen J, Chang WC, Hsu J, Hung MC, Chen YW, Huang PI, Yang YP, Li CP, Ma HI, Chen CH, Lin WC, Chiou SH*.  Musashi-1 Promotes Stress-Induced Tumor Progression through Recruitment of AGO2. Theranostics 2020 Jan; 10(1): 201-17. (IF: 8.579; Medicine, Research & Experimental 10/138)

  13. YL Lo*, CH Chang, CS Wang, MH Yang, AM Lin, CJ Hong, WH Tseng.  PEG-Coated Nanoparticles Detachable in Acidic Microenvironments for the Tumor-Directed Delivery of Chemo- and Gene Therapies for Head and Neck Cancer. Theranostics 2020 May; 10(15): 6695-714. (IF: 8.579; Medicine, Research & Experimental 10/138)

  14. Chen MH, Chen MH, Chou CT, Hou MC, Tsai CY*, Huang YH*.  Low but Long-Lasting Risk of Reversal of Seroconversion in Patients with Rheumatoid Arthritis Receiving Immunosuppressive Therapy. Clin Gastroenterol Hepatol 2020 Oct; 18(11): 2573-81. Epub 2020 Mar. (IF: 8.549; Gastroenterology & Hepatology 10/88)

  15. Lai HT, Chiang CT, Tseng WK, Chao TC, Su Y*.  GATA6 Enhances the Stemness of Human Colon Cancer Cells by Creating a Metabolic Symbiosis through Upregulating LRH-1 Expression. Mol Oncol 2020 Jun; 14(6): 1327-47. Epub 2020 Feb. (IF: 6.574; Oncology 35/244)

  16. YR Pan, CE Wu, YC Wang, YC Yeh, ML Lu, YP Hung, Y Chao, DW Yeh, CH Lin, JC Hsieh, MH Chen*, CN Yeh*.  Establishment of a Novel Gene Panel as a Biomarker of Immune Checkpoint Inhibitor Response. Clin Transl Immunology 2020 Jun; 9(7): e1145. (IF: 6.464; Immunology 25/158)

  17. Wu KS, Ho DM, Jou ST, Yu AL, Tran HM, Liang ML, Chen HH, Lee YY, Chen YW, Lin SC, Chang FC, Tsai ML, Liu YL, Lee HL, Hsieh KL, Huang WC, Sung SY, Chang CC, Changou CA, Liang KH, Hsieh TH, Liu YR, Chao ME, Chen W, Chu SS, Cho EC*, Wong TT*.  Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan. Cancers (Basel) 2020 Mar; 12(3): 653. (IF: 6.126; Oncology 37/244)

  18. YM Liu, TH Wu, YH Chiu, H Wang, TL Li, S Hsia, YL Chan*, CJ Wu*.  Positive Effects of Preventive Nutrition Supplement on Anticancer Radiotherapy in Lung Cancer Bearing Mice. Cancers (Basel) 2020 Aug; 12(9): E2445. (IF: 6.126; Oncology 37/244)

  19. Lee PC, Chao Y*, Chen MH, Lan KH, Lee CJ, Lee IC, Chen SC, Hou MC, Huang YH*.  Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma. Cancers (Basel) 2020 Jan; 12(1): 182. (IF: 6.126; Oncology 37/244)

  20. KH Huang, MH Chen, WL Fang*, CH Lin, Y Chao, SS Lo, AF Li, CW Wu, YM Shyr.  The Clinicopathological Characteristics and Genetic Alterations of Signet-Ring Cell Carcinoma in Gastric Cancer. Cancers (Basel) 2020 Aug; 12(8): E2318. (IF: 6.126; Oncology 37/244)

  21. WL Fang*, MH Chen, KH Huang, CH Lin, Y Chao, SS Lo, AF Li, CW Wu, YM Shyr.  The Clinicopathological Features and Genetic Alterations in Epstein-Barr Virus-Associated Gastric Cancer Patients after Curative Surgery. Cancers (Basel) 2020 Jun; 12(6): 1517. (IF: 6.126; Oncology 37/244)

  22. Fang WL*, Chen MH, Huang KH, Chang SC, Lin CH, Chao Y, Lo SS, Li AF, Wu CW, Shyr YM.  The Clinicopathological Features and Genetic Mutations in Gastric Cancer Patients According to EMAST and MSI Status. Cancers (Basel) 2020 Feb; 12(3): 551. (IF: 6.126; Oncology 37/244)

  23. Papadimitrakopoulou VA*, Han JY, Ahn MJ, Ramalingam SS, Delmonte A, Hsia TC, Laskin J, Kim SW, He Y, Tsai CM, Hida T, Maemondo M, Kato T, Jenkins S, Patel S, Huang X, Laus G, Markovets A, Thress KS, Wu YL, Mok T.  Epidermal Growth Factor Receptor Mutation Analysis in Tissue and Plasma from the AURA3 Trial: Osimertinib Versus Platinum-Pemetrexed for T790M Mutation-Positive Advanced Non-Small Cell Lung Cancer. Cancer 2020 Jan; 126(2): 373-80. Epub 2019 Nov. (IF: 6.102; Oncology 32/230)

  24. BY Ryoo, P Merle, AS Kulkarni, AL Cheng, M Bouattour, HY Lim, V Breder, J Edeline, Y Chao, S Ogasawara, T Yau, M Garrido, SL Chan, B Daniele, JM Norquist, E Chen, AB Siegel, AX Zhu, RS Finn, M Kudo*.  Health-Related Quality-of-Life Impact of Pembrolizumab versus Best Supportive Care in Previously Systemically Treated Patients with Advanced Hepatocellular Carcinoma: KEYNOTE-240. Cancer 2020 Nov. [Epub ahead of print] (IF: 5.772; Oncology 46/244)

  25. Huang TT, Tseng LM, Chen JL, Chu PY, Lee CH, Huang CT, Wang WL, Lau KY, Tseng MF, Chang YY, Chiang TY, Ueng YF, Lee HC, Dai MS, Liu CY*.  Kynurenine 3-Monooxygenase Upregulates Pluripotent Genes Through β-Catenin and Promotes Triple-Negative Breast Cancer Progression. EBioMedicine 2020 Apr; 54(): 102717. (IF: 5.736; Medicine, Research & Experimental 18/139)

  26. Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N*.  A Phase 3 Study of Nivolumab in Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (ATTRACTION-2): 2-Year Update Data. Gastric Cancer 2020 May; 23(3): 510-9. Epub 2019 Dec. (IF: 5.554; Gastroenterology & Hepatology 15/84; Oncology 42/230)

  27. Satoh T, Kang YK, Chao Y, Ryu MH, Kato K, Cheol Chung H, Chen JS, Muro K, Ki Kang W, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Tanimoto M, Chen LT, Boku N*.  Exploratory Subgroup Analysis of Patients with Prior Trastuzumab Use in the ATTRACTION-2 Trial: a Randomized Phase III Clinical Trial Investigating the Efficacy and Safety of Nivolumab in Patients with Advanced Gastric/Gastroesophageal Junction Cancer. Gastric Cancer 2020 Jan; 23(1): 143-53. Epub 2019 May. (IF: 5.554; Gastroenterology & Hepatology 15/84; Oncology 42/230)

  28. Chen MH*, Chou WC, Hsiao CF, Jiang SS, Tsai HJ, Liu YC, Hsu C, Shan YS, Hung YP, Hsich CH, Chiu CH, Liu TC, Cho SF, Liu TW, Chao Y.  An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas. Oncologist 2020 May; 25(5): e782-8. Epub 2019 Dec. (IF: 5.252; Oncology 46/229)

  29. NJ Chiang, MH Chen, SH Yang, C Hsu, CJ Yen, HH Tsou, YY Su, JS Chen, YS Shan, LT Chen*.  Multicentre, Phase II Study of Gemcitabine and S-1 in Patients with Advanced Biliary Tract Cancer: TG1308 Study. Liver Int 2020 Oct; 40(10): 2535-43. Epub 2020 Jun. (IF: 5.175; Gastroenterology & Hepatology 19/88)

  30. Lin ZZ, Chen BB, Hung YP, Huang PH, Shen YC, Shao YY, Hsu CH, Cheng AL, Lee RC, Chao Y*, Hsu C*.  A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy. Oncologist 2020 Sep; 25(9): e1280-5. Epub 2020 Apr. (IF: 5.025; Oncology 63/244)

  31. TY Lai, CM Yeh, YW Hu, CJ Liu*.  Hospital Volume and Physician Volume in Association with Survival in Patients with Nasopharyngeal Cancer after Radiation Therapy. Radiother Oncol 2020 Oct; 151(): 190-9. Epub 2020 Jul. (IF: 4.856; Radiology, Nuclear Medicine & Medical Imaging 17/133; Oncology 68/244)

  32. JI Lai, YJ Tseng, MH Chen, CF Huang, PM Chang*.  Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics. Front Oncol 2020 Nov. [Epub ahead of print] (IF: 4.848; Oncology 69/244)

  33. CC Lin, TT Liao*, MH Yang*.  Immune Adaptation of Colorectal Cancer Stem Cells and Their Interaction with the Tumor Microenvironment. Front Oncol 2020 Nov. [Epub ahead of print] (IF: 4.848; Oncology 69/244)

  34. NY Sun, MH Yang*.  Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy. Front Oncol 2020 May. [Epub ahead of print] (IF: 4.848; Oncology 69/244)

  35. LW Hsu, KH Huang, MH Chen, WL Fang*, Y Chao, SS Lo, AF Li, CW Wu, YM Shyr.  Genetic Alterations in Gastric Cancer Patients According to Sex. Aging (Albany NY) 2020 Dec; 13(1): 376-88. (IF: 4.831; Geriatrics & Gerontology 7/51; Cell Biology 62/195)

  36. CW Wu, MH Chen, KH Huang, SC Chang, WL Fang*, CH Lin, Y Chao, SS Lo, AF Li, YM Shyr.  The Clinicopathological Characteristics and Genetic Alterations between Younger and Older Gastric Cancer Patients with Curative Surgery. Aging (Albany NY) 2020 Aug; 12(18): 18137-50. (IF: 4.831; Geriatrics & Gerontology 7/51; Cell Biology 62/195)

  37. WY Lin, HH Wang, YW Chen, CF Lin, HC Fan, YY Lee*.  Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies. Int J Mol Sci 2020 Nov; 21(22): 8655. (IF: 4.556; Biochemistry & Molecular Biology 74/297; Chemistry, Multidisciplinary 48/177)

  38. Chung SY, Huang WC, Chen ZS, Chao TC, Su Y*.  Elucidation of the Mechanism Underlying CD44v6-Induced Transformation of IEC-6 Normal Intestinal Epithelial Cells. J Cell Physiol 2020 Jan; 235(1): 194-209. Epub 2019 Jun. (IF: 4.522; Physiology 11/81; Cell Biology 64/193)

  39. Lai HT, Tseng WK, Huang SW, Chao TC, Su Y*.  MicroRNA-203 Diminishes the Stemness of Human Colon Cancer Cells by Suppressing GATA6 Expression. J Cell Physiol 2020 Mar; 235(3): 2866-80. Epub 2019 Sep. (IF: 4.522; Physiology 11/81; Cell Biology 64/193)

  40. Liao TT, Yang MH*.  Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms. Cells 2020 Mar; 9(3): 623. (IF: 4.366; Cell Biology 70/195)

  41. TC Lai, CY Fang, YH Jan, HL Hsieh, YF Yang, CY Liu, PM Chang*, M Hsiao*.  Kinase shRNA Screening Reveals that TAOK3 Enhances Microtubule-Targeted Drug Resistance of Breast Cancer Cells via the NF-κB Signaling Pathway. Cell Commun Signal 2020 Oct; 18(1): 164. (IF: 4.344; Cell Biology 71/195)

  42. YR Pan, CE Wu, MH Chen, WK Huang, HJ Shih, KL Lan*, CN Yeh*.  Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model. Vaccines (Basel) 2020 Nov; 8(4): 703. (IF: 4.086; Medicine, Research & Experimental 50/139; Immunology 59/159)

  43. YC Chang, MH Chen, CN Yeh, M Hsiao*.  Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma. Biomolecules 2020 Sep; 10(10): E1377. (IF: 4.082; Biochemistry & Molecular Biology 98/297)

  44. JH Chiu*, LM Tseng, TT Huang, CY Liu, JY Wang, CP Huang, YF Tsai, CY Hsu.  MEGF11 is Related to Tumour Recurrence in Triple Negative Breast Cancer via Chemokine Upregulation. Sci Rep 2020 May; 10(1): 8060. (IF: 3.998; Multidisciplinary Sciences 17/71)

  45. TY Cheng, PC Lee, YT Chen, Y Chao, MC Hou, YH Huang*.  Pre-Sarcopenia Determines Post-Progression Outcomes in Advanced Hepatocellular Carcinoma after Sorafenib Failure. Sci Rep 2020 Oct; 10(1): 18375. (IF: 3.998; Multidisciplinary Sciences 17/71)

  46. Grünwald V, Chirovsky D, Cheung WY, Bertolini F, Ahn MJ, Yang MH, Castro G, Berrocal A, Sjoquist K, Kuyas H, Auclair V, Guillaume X, Joo S, Shah R, Harrington K.  Global Treatment Patterns and Outcomes among Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of the GLANCE H&N Study. Oral Oncol 2020 Mar; 102(): 104526. Epub 2020 Jan. (IF: 3.979; Dentistry, Oral Surgery & Medicine 5/91; Oncology 89/244)

  47. TY Lin, MY Lan, HH Tsou, CY Ho, CW Twu, YC Liu, PJ Lin, PI Huang, CY Shiau, JC Lin*.  Survival Impacts of Different Nodal Characteristics and T-Classification in N3 Nasopharyngeal Carcinoma Patients. Oral Oncol 2020 Sep; 108(): 104820. Epub 2020 Jun. (IF: 3.979; Dentistry, Oral Surgery & Medicine 5/91; Oncology 89/244)

  48. Yang WC, Yen HJ, Liang ML, Chen HH, Lee YY, Chang FC, Lin SC, Wong TT, Hu YW*, Chen YW*.  Effect of Early Radiotherapy Initiation and High-Dose Chemotherapy on the Prognosis of Pediatric Atypical Teratoid Rhabdoid Tumors in Different Age Groups. J Neurooncol 2020 May; 147(3): 619-31. Epub 2020 Mar. (IF: 3.267; Clinical Neurology 69/204; Oncology 126/244)

  49. BZ Lin, SY Wan, MY Lin, CH Chang, TW Chen, MH Yang, YJ Lee*.  Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated 188 Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor. Molecules 2020 Aug; 25(16): E3609. (IF: 3.267; Chemistry, Multidisciplinary 70/177; Biochemistry & Molecular Biology 141/297)

  50. Huang CY, Lee CC, Yang HC, Lin CJ, Wu HM, Chung WY, Shiau CY, Guo WY, Pan DH, Peng SJ*.  Radiomics as Prognostic Factor in Brain Metastases Treated with Gamma Knife Radiosurgery. J Neurooncol 2020 Feb; 146(3): 439-49. (IF: 3.267; Clinical Neurology 69/204; Oncology 126/244)

  51. YY Lin, HM Wu, HC Yang, CJ Chen, CJ Lin, YW Chen, HH Chen, TT Wong, YS Hu, WY Chung, CY Shiau, WY Guo, DH Pan, CC Lee*.  Repeated Gamma Knife Radiosurgery Enables Longer Tumor Control in Cases of Highly-Recurrent Intracranial Ependymoma. J Neurooncol 2020 Jun; 148(2): 363-72. Epub 2020 May. (IF: 3.267; Clinical Neurology 69/204; Oncology 126/244)

  52. Tai CC, Chen WS, Jiang JK, Yang SH, Wang HS, Chang SC, Lan YT, Lin CC, Lin HH, Huang SC, Cheng HH, Chao Y, Teng HW*.  Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer. Am J Clin Oncol 2020 Jan; 43(1): 28-34. Epub 2019 Nov. (IF: 3.015; Oncology 116/230)

  53. CA Liu, IC Lee, RC Lee, JL Chen, Y Chao, MC Hou, YH Huang*.  Prediction of Survival According to Kinetic Changes of Cytokines and Hepatitis Status Following Radioembolization with Yttrium-90 Microspheres. J Formos Med Assoc 2020 Sep. [Epub ahead of print] (IF: 3.008; Medicine, General & Internal 42/165)

  54. YP Hung, YY Shao, C Hsu, CH Hsu, JM Lee, MH Yang*, Y Chao.  The Unique Characteristic in Peripheral Immune Cells in Patients with Advanced Hepatocellular Carcinoma. J Formos Med Assoc 2020 Dec. [Epub ahead of print] (IF: 3.008; Medicine, General & Internal 42/165)

  55. CE Wu, DW Yeh, YR Pan, WK Huang, MH Chen, JW Chang, JS Chen, YC Wang*, CN Yeh*.  Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis. Life (Basel) 2020 Nov. [Epub ahead of print] (IF: 2.991; Biology 26/93)

  56. Young SH, Chau GY, Lee IC, Yeh YC, Chao Y, Huo TI, Su CW, Lin HC, Hou MC, Lee MH*, Huang YH*.  Aspirin is Associated with Low Recurrent Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Patients after Curative Resection. J Formos Med Assoc 2020 Jan; 119(1 Pt 2): 218-29. Epub 2019 May. (IF: 2.844; Medicine, General & Internal 35/160)

  57. Chang KB, Ye BW, Chou CK, Lee IC, Li CP, Chao Y, Huang YH, Hou MC, Lee KC*.  Outcomes of Enteral Metallic Stent in Patients with Pancreatic Carcinoma and Gastric Outlet Obstruction: A Single Center Experience. J Formos Med Assoc 2020 Jan; 119(1 Pt 2): 238-46. Epub 2019 Jun. (IF: 2.844; Medicine, General & Internal 35/160)

  58. Chi CT, Chau GY, Lee RC, Chen YY, Lei HJ, Hou MC, Chao Y, Huang YH*.  Radiological Features and Outcomes of Combined Hepatocellular-Cholangiocarcinoma in Patients Undergoing Surgical Resection. J Formos Med Assoc 2020 Jan; 119(1 Pt 1): 125-33. Epub 2019 Mar. (IF: 2.844; Medicine, General & Internal 35/160)

  59. Chien SH, Liu HM, Chen PM, Ko PS, Lin JS, Chen YJ, Lee LH, Hsiao LT, Chiou TJ, Gau JP, Yang MH, Liu CY*.  The Landscape of BCR-ABL Mutations in Patients with Philadelphia Chromosome-Positive Leukaemias in the Era of Second-Generation Tyrosine Kinase Inhibitors. Hematol Oncol 2020 Aug; 38(3): 390-8. Epub 2020 Feb. (IF: 2.832; Hematology 38/76; Oncology 149/244)

  60. HY Hung, YH Tseng, HS Chao, CH Chiu, WH Hsu, HS Hsu, YC Wu, TY Chou, CK Chen, KL Lan, YW Chen, YH Wu, YM Chen*.  Multidisciplinary Team Discussion Results in Survival Benefit for Patients with Stage III Non-Small-Cell Lung Cancer. PLoS One 2020 Oct; 15(10): e0236503. (IF: 2.740; Multidisciplinary Sciences 27/71)

  61. Yan X, Cao N, Chen Y, Lan HY, Cha JH, Yang WH*, Yang MH*.  MT4-MMP Promotes Invadopodia Formation and Cell Motility in FaDu Head and Neck Cancer Cells. Biochem Biophys Res Commun 2020 Feb; 522(4): 1009-14. Epub 2019 Dec. (IF: 2.705; Biophysics 28/73; Biochemistry & Molecular Biology 157/299)

  62. Teng HW*, Lin JK, Lin TC, Chen WS, Jiang JK, Yang SH, Wang HS, Chang SC, Lan YT, Lin CC, Lin HH, Huang SC.  Planned Short-Course Radiation (scRT) is Superior to Upfront Concurrent Chemoradiation (CCRT) in Treating Metastatic Rectal Cancer. J Gastrointest Surg 2020 May; 24(5): 1092-100. Epub 2019 May. (IF: 2.686; Surgery 58/203; Gastroenterology & Hepatology 55/84)

  63. Wu WH, Li FY, Shu YC, Lai JM, Chang PM, Huang CY, Wang FS*.  Oncogene Inference Optimization Using Constraint-Based Modelling Incorporated with Protein Expression in Normal and Tumour Tissues. R Soc Open Sci 2020 Mar; 7(3): 191241. (IF: 2.646; Multidisciplinary Sciences 28/71)

  64. CH Wu, KH Huang, MH Chen, WL Fang*, Y Chao, SS Lo, AF Li, CW Wu, YM Shyr.  Comparison of the Long-Term Outcome Between Billroth-I and Roux-en-Y Reconstruction Following Distal Gastrectomy for Gastric Cancer. J Gastrointest Surg 2020 Nov. [Epub ahead of print] (IF: 2.573; Surgery 65/210; Gastroenterology & Hepatology 61/88)

  65. TH Chen, WS Chen, JK Jiang, SH Yang, HS Wang, SC Chang, YT Lan, CC Lin, HH Lin, SC Huang, HH Cheng, GY Chau, CY Hsia, HJ Lei, SC Chou, Y Chao, HW Teng*.  Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver Metastasis. J Gastrointest Surg 2020 Nov. [Epub ahead of print] (IF: 2.573; Surgery 65/210; Gastroenterology & Hepatology 61/88)

  66. T Kanai, A Paz, W Furuichi, CS Liu, P He, S Mori*.  Four-Dimensional Carbon-Ion Pencil Beam Treatment Planning Comparison between Robust Optimization and Range-Adapted Internal Target Volume for Respiratory-Gated Liver and Lung Treatment. Phys Med 2020 Dec; 80(): 277-87. Epub 2020 Nov. (IF: 2.485; Radiology, Nuclear Medicine & Medical Imaging 60/134)

  67. HJ Lu, SW Tseng, CY Peng, HC Tseng, CH Hsin, HL Chen, WS Huang, MF Wu, MH Yang, PM Chang*.  Predictors of Early Progression after Curative Resection Followed by Platinum-Based Adjuvant Chemoradiotherapy in Oral Cavity Squamous Cell Carcinoma. Postgrad Med 2020 Aug. [Epub ahead of print] (IF: 2.464; Medicine, General & Internal 55/165)

  68. Yang YH, Chiu CC, Teng HW, Huang CT, Liu CY, Huang LJ*.  Aspirin and Risk of Dementia in Patients with Late-Onset Depression: A Population-Based Cohort Study. Biomed Res Int 2020 Jan; 2020(): 1704879. (IF: 2.276; Biotechnology & Applied Microbiology 92/156; Medicine, Research & Experimental 92/139)

  69. WY Lin, YW Chen, CF Lin, YP Yang, ML Wang, KF Hung, PI Huang, YY Lee*, SH Chiou*.  Emerging Trends in Gene-Modified-Based Chimeric Antigen Receptor-Engineered T-Cellular Therapy for Malignant Tumors: The Lesson from Leukemia to Pediatric Brain Tumors. J Chin Med Assoc 2020 Aug; 83(8): 719-24. (IF: 2.170; Medicine, General & Internal 63/165)

  70. CH Liu, HY Huang, YF Tu, WY Lai, CL Wang, JR Sun, Y Chien, TW Lin, YY Lin, CS Chien, CH Huang, YM Chen, PI Huang, FD Wang, YP Yang*.  Highlight of SARS-CoV-2 Vaccine Development Against COVID-19 Pandemic. J Chin Med Assoc 2020 Nov. [Epub ahead of print] (IF: 2.170; Medicine, General & Internal 63/165)

  71. Kang YM, Lan A, Huang YH, Hsu KM, Chao Y, Lan KL*.  Identification of Key Genes and Pathways Associated With Topotecan Treatment Using Multiple Bioinformatics Tools. J Chin Med Assoc 2020 May; 83(5): 446-53. Epub 2020 Apr. (IF: 2.170; Medicine, General & Internal 63/165)

  72. Chen MH*, Fang WL, Hung YP, Chao Y.  Mucinous Gastric Adenocarcinoma: A Good Candidate for Immune Therapy? J Chin Med Assoc 2020 Jul; 83(7): 624-5. Epub 2020 Apr. (IF: 2.170; Medicine, General & Internal 63/165)

  73. CY Liu, MC Lee, HF Lin, YY Lin, WY Lai, Y Chien, TI Huo, WL Lo, YT Lan, SH Chiou, YW Chen, PI Huang, YY Liu, MY Yang*.  Nanodiamond-Based MicroRNA Delivery System Promotes Pluripotent Stem Cells toward Myocardiogenic Reprogramming. J Chin Med Assoc 2020 Sep. [Epub ahead of print] (IF: 2.170; Medicine, General & Internal 63/165)

  74. PM Chang*.  Pulmonary Embolism: A Warning Sign of Occult Malignancy. J Chin Med Assoc 2020 Aug; 83(8): 693-4. Epub 2020 Jun. (IF: 2.170; Medicine, General & Internal 63/165)

  75. Tseng CH, Fang WL*, Huang KH, Chen MH, Chao Y, Lo SS, Li AF, Wu CW, Shyr YM.  The Clinicopathological Characteristics and Genetic Alterations of Mucinous Carcinoma of the Stomach. J Chin Med Assoc 2020 Feb; 83(2): 141-7. (IF: 2.170; Medicine, General & Internal 63/165)

  76. CY Lum, KH Huang, MH Chen, WL Fang*, Y Chao, SS Lo, AF Li, CW Wu, YM Shyr.  The Clinicopathological Characteristics and Prognosis of Node-Positive Gastric Cancer Patients after Curative Surgery. J Chin Med Assoc 2020 Aug; 83(8): 751-5. Epub 2020 Apr. (IF: 2.170; Medicine, General & Internal 63/165)

  77. Chou CJ, Lin CF, Chen YW, Huang PI, Yang YP, Wang ML, Hung KF, Lee YY*.  The Update of Chimeric Antigen Receptor (CAR) -T Cells Therapy in Glioblastoma. J Chin Med Assoc 2020 May; 83(5): 442-5. Epub 2020 Mar. (IF: 2.170; Medicine, General & Internal 63/165)

  78. Lin YC*, Chou FI, Yang BH, Chang CW, Chen YW, Hwang JJ.  Similar T/N Ratio between 18F-FBPA Diagnostic and BPA Therapeutic Dosages for Boron Neutron Capture Therapy in Orthotropic Tongue Cancer Model. Ann Nucl Med 2020 Jan; 34(1): 58-64. Epub 2019 Oct. (IF: 1.648; Radiology, Nuclear Medicine & Medical Imaging 88/129)

  79. YC Huang, HH Chang, MH Chen, KH Huang, AF Li, CH Lin, YM Shyr, WL Fang*.  Somatic SDHA Mutations in Paragangliomas in Siblings: Case Report of 2 Cases. Medicine (Baltimore) 2020 Oct; 99(41): e22497. (IF: 1.552; Medicine, General & Internal 89/165)

  80. Kang YM, Lin SC, Lee YY, Chang FC, Liang ML, Chen HH, Wong TT, Chen YW*.  A Single-Center Study of Treatment Outcomes of Pediatric Basal Ganglia Germinoma in Taiwan. Childs Nerv Syst 2020 Aug; 36(8): 1745-53. Epub 2020 Feb. (IF: 1.298; Pediatrics 94/128; Surgery 157/210; Clinical Neurology 176/204)

  81. DS Quah*, YW Chen, YH Wu.  Dosimetric Comparison of Boron Neutron Capture Therapy, Proton Therapy and Volumetric Modulated Arc Therapy for Recurrent Anaplastic Meningioma. Appl Radiat Isot 2020 Dec; 166(): 109301. Epub 2020 Jul. (IF: 1.270; Nuclear Science & Technology 16/34; Chemistry, Inorganic & Nuclear 33/45; Radiology, Nuclear Medicine & Medical Imaging 111/133)

  82. YH Hung, YC Lin, YT Lin, GW Shih, JW Liao, KS Chen, HM Liu, YW Chen, YJ Chuang, CM Yang, JJ Peir, CH Yang, FI Chou*.  Suitability of Boric Acid as a Boron Drug for Boron Neutron Capture Therapy for Hepatoma. Appl Radiat Isot 2020 Oct; 164(): 109254. Epub 2020 May. (IF: 1.270; Nuclear Science & Technology 16/34; Chemistry, Inorganic & Nuclear 33/45; Radiology, Nuclear Medicine & Medical Imaging 111/133)

  83. YW Lo, JC Lee, YS Hu, CY Li, YL Chen, CS Lin, WS Huang, KH Lin*, YW Chen*.  The Importance of Optimal ROIs Delineation for FBPA-PET before BNCT. Appl Radiat Isot 2020 Sep; 163(): 109219. Epub 2020 May. (IF: 1.270; Nuclear Science & Technology 16/34; Chemistry, Inorganic & Nuclear 33/45; Radiology, Nuclear Medicine & Medical Imaging 111/133)

  84. Jiang SH*, Liu YWH, Chou FI, Liu HM, Peir JJ, Liu YH, Huang YS, Wang LW, Chen YW, Yen SH, Wu YH, Liu CS, Lee JC, Chang CW, Wang SJ, Huang WS, Kai JJ.  The Overview and Prospects of BNCT Facility at Tsing Hua Open-Pool Reactor. Appl Radiat Isot 2020 Jul; 161(): 109143. Epub 2020 Mar. (IF: 1.270; Nuclear Science & Technology 16/34; Chemistry, Inorganic & Nuclear 33/45; Radiology, Nuclear Medicine & Medical Imaging 111/133)

  85. TL Lan*, FI Chou, KH Lin, PS Pan, JC Lee, WS Huang, YM Liu, Y Chao, YW Chen*.  Using Salvage Boron Neutron Capture Therapy (BNCT) for Recurrent Malignant Brain Tumors in Taiwan. Appl Radiat Isot 2020 Jun; 160(): 109105. Epub 2020 Feb. (IF: 1.270; Nuclear Science & Technology 16/34; Chemistry, Inorganic & Nuclear 33/45; Radiology, Nuclear Medicine & Medical Imaging 111/133)

  86. YY Pan, SF Yao, KH Lin, FI Chou, JC Lee, SK Tai, WS Huang, KL Lan, Y Chao, YW Chen*.  Boron Neutron Capture Therapy as Salvage Treatment for Recurrent Papillary Thyroid Carcinoma—A Case Report. Therapeutic Radiology and Oncology 2020 Sep; 4: 21.

  87. CS Lin, YM Kang, KL Lan, LW Wang, YM Liu, PI Huang, YW Hu, IC Lai, YH Wu, TY Lai, WC Yang, JC Lee, CY Shiau*.  Treatment and Outcome of Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis Patients Receiving Radiotherapy in Taiwan: A Single-Center Experience. Therapeutic Radiology and Oncology 2020 Sep; 4: 14.

  88. YW Chen*, TL Lan, YY Lee, KH Lin, ML Liang, HH Chen, PS Pan, FC Chang, CC Wu, SC Lin, YM Kang, JC Lee, HM Liu, KH Chen, JK Chen, CF Lin, YC Kuo, SM Hsu, WS Huang, FI Chou.  Using Precise Boron Neutron Capture Therapy as a Salvage Treatment for Pediatric Patients with Recurrent Brain Tumors. Therapeutic Radiology and Oncology 2020 Dec; 4: 30.

 

最後更新:

回到最上